α-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy

Experimental Neurology

Volumn 181, Issue 1, 2003, Pages 68-78

  Gai, W P ^a,e   Pountney, D L ^a   Power, J H T ^a   Li, Q X ^b   Culvenor, J G ^b   McLean, C A ^b   Jensen, P H ^c   Blumbergs, P C ^d  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AARHUS UNIVERSITY   (Denmark)

^d INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^e FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Electron microscopy; Image analysis; Multiple system atrophy; Oligodendroglial inclusions; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; AMINO ACID; EPITOPE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BRAIN SLICE; CARBOXY TERMINAL SEQUENCE; CELL INCLUSION; CELL SURFACE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; IMMUNOGOLD ELECTRON MICROSCOPY; IMMUNOGOLD LABELING; INTERMEDIATE FILAMENT; NERVE FIBER; OLIGODENDROGLIA; PRIORITY JOURNAL; SHY DRAGER SYNDROME; TISSUE SECTION;

EID: 0037404112     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00004-9     Document Type: Article

References (38)

1. Arima K., Uéda K., Sunohara N., Arakawa K., Hirai S., Nakamura M., Tonozuka-Uehara H., Kawai M. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. Acta Neuropathol. 96:1998;439-444.
2. Cole N.B., Murphy D.D., Grider T., Rueter S., Brasaemle D., Nussbaum R.L. Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein. J. Biol. Chem. 277:2002;6344-6352.
3. Conway K.A., Harper J.D., Lansbury P.T. Jr. Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat. Med. 11:1998;1318-1320.
4. Conway K.A., Harper J.D., Lansbury P.T. Jr. Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry. 39:2000;2551-2563.
5. Crowther R.A., Daniel S.E., Goedert M. Characterisation of isolated α-synuclein filaments from substantia nigra of Parkinson's disease brain. Neurosci. Lett. 292:2000;128-130.
6. Culvenor J.G., McLean C.A., Cutt S., Campbell B.C.V., Maher F., Jäkälä P., Hartmann T., Beyreuther K., Masters C.L., Li Q.-X. Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited NAC and α-synuclein are not associated with Aβ amyloid. Am. J. Pathol. 155:1999;1173-1181.
7. Culvenor J.G., Rietze R.L., Bartlett P.F., Masters C.L., Li Q.-X. Oligodendrocytes from neural stem cells express α-synuclein increased numbers from presenilin I deficient mice. NeuroReport. 19:2002;1305-1308.
8. Dickson D.W., Lin W.-I., Liu W.-K., Yen S.-H. Multiple system atrophy a sporadic synucleinopathy. Brain Pathol. 9:1999;721-732.
9. Duda J.E., Giasson B.I., Gur T.L., Montine T.J., Robertson D., Biaggioni I., Hurtig H.I., Stern M.B., Gollomp S.M., Grossman M., Lee V.M.-Y., Trojanowski J.Q. Immunohistochemical and biochemical studies demonstrate a distinct profile of α-synuclein permutations in multiple system atrophy. J. Neuropathol. Exp. Neurol. 59:2000;830-841.
10. Eliezer D., Kutluay E., Bussell R. Jr., Browne G. Conformational proterties of α-synuclein in its free and lipid-associated states. J. Mol. Biol. 307:2001;1061-1073.
11. Forno L.S. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55:1996;259-272.
12. Gai W.P., Power J.H.T., Blumbergs P.C., Culvenor J.G., Jensen P.H. α-Synuclein immunoisolation of glial inclusions from multiple system atrophy brain tissue reveals multiprotein components. J. Neurochem. 73:1999;2093-2100.
13. Gai W.P., Yuan H.X., Li X.Q., Power J.T.H., Blumbergs P.C., Jensen P.H. In situ and in vitro study of colocalization and segregation of α-synuclein, ubiquitin, and lipids in Lewy bodies. Exp. Neurol. 166:2000;324-333.
14. Galloway P.G., Mulvihill P., Perry G. Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am. J. Pathol. 140:1992;809-822.
15. Giasson B.I., Murray I.V., Trojanowski J.Q., Lee V.M. A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J. Biol. Chem. 276:2001;2380-2386.
16. Giasson B.I., Uryu K., Trojanowski J.Q., Lee V.M.-Y. Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro. J. Biol. Chem. 274:1999;7619-7622.
17. Gilman S., Low P.A., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C.J., Kaufmann H., Klockgether T., Lang A.E., Lantos P.L., Litvan I., Mathias C.J., Oliver E., Robertson D., Schatz I., Wenning G.K. Consensus statement on the diagnosis of multiple system atrophy. J. Auton. Nerv. Syst. 74:1998;189-192.
18. Goedert M. α-Synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2:2001;492-501.
19. Iwai A., Masliah E., Yoshimoto M., Ge N., Flanagan L., de Silva H.A.R., Kittel A., Saitoh T. The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron. 14:1995;467-475.
20. Iwatsubo T., Yamaguchi H., Fujimuro M., Yokosawa H., Ihara Y., Trojanowski J.Q., Lee V.M.-Y. Purification and characterization of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am. J. Pathol. 148:1996;1517-1529.
21. Jensen P.H., Islam K., Kenney J., Nielsen M.S., Power J., Gai W.P. Microtubule-associated protein 1B is a component of cortical Lewy bodies and binds α-synuclein filaments. J. Biol. Chem. 275:2000;21500-21507.
22. Kahle P.J., Neumann M., Ozmen L., Muller V., Jacobsen H., Spooren W., Fuss B., Mallon B., Macklin W.B., Fujiwara H., Hasegawa M., Iwatsubo T., Kretzschmar H.A., Haass C. Hyperphosphorylation and insolubility of {alpha}-synuclein in transgenic mouse oligodendrocytes. EMBO Rep. 3:2002;583-588.
23. Kato S., Nakamura H. Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy immunohistochemical and ultrastructural studies. Acta Neuropathol. 79:1990;584-594.
24. Kato S., Nakamura H., Hirano A., Ito H., Llena J.F., Yen S.H. Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy). Acta Neuropathol. 82:1991;488-493.
25. Lantos P.L. The definition of multiple system atrophy a review of recent developments. J. Neuropathol. Exp. Neurol. 57:1998;1099-1111.
26. Miake H., Mizusawa H., Iwatsubo T., Hasegawa M. Biochemical characterization of the core structure of alpha-synuclein filaments. J. Biol. Chem. 277:2002;19213-19219.
27. Miller D.W., Solano S.M., Standaert D.G., Young A.B. Expression of α-synuclein mRNA in multiple system atrophy. Soc. Neurosci. Abstr. 30:2000;233.
28. Narhi L., Wood S.J., Steavenson S., Jiang Y., Wu G.M., Anafi D., Kaufman S.A., Matin F., Sitney K., Denis P., Louis J.-C., Wypych J., Biere L.A., Citron M. Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274:1999;9843-9846.
29. Ozawa T., Okuizumi K., Ikeuchi T., Wakabayashi K., Takahashi H., Tsuji S. Analysis of the expression level of α-synuclein mRNA using postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol. 102:2001;188-190.
30. Papp M.I., Kahn J.E., Lantos P.L. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J. Neurol. Sci. 94:1989;79-100.
31. Perrin R.J., Woods W.S., Clayton D.F., George J.M. Interaction of human α-synuclein and Parkinson's disease variatnts with phospholipids. J. Biol. Chem. 275:2000;34393-34398.
32. Richter-Landsberg C., Gorath M., Trojanowski J.Q., Lee V.M.-Y. α-Synuclein is developmentally expressed in cultured rat brain oligodendrocytes. J. Neurosci. Res. 62:2000;9-14.
33. Serpell L.C., Berruman J., Jakes R., Goedert M., Crowther R.A. Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross conformation. Proc. Natl. Acad. Sci. USA. 97:2000;4897-4902.
34. Spillantini M.G., Crowther R.A., Jakes R., Cairns N.J., Lantos P.L., Goedert M. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 251:1998;205-208.
35. Takeda A., Hashimoto M., Mallory M., Sundsumo M., Hansen L., Sisk A., Masliah E. Abnormal distribution of the non-ab component of Alzheimer's disease precursor/a-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab. Invest. 78:1998;1169-1177.
36. Tu P.-H., Galvin J.E., Baba M., Giasson B., Tomita T., Leight S., Iwatsubo T., Trojanowski J.Q., Lee V.M.-Y. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann. Neurol. 44:1998;415-422.
37. Weinreb P.H., Zhen W., Poon A.W., Conway K.A., Lansbury P.T. Jr. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. Biochemistry. 35:1996;13709-13715.
38. Yogalingam G., Doyle I.R., Power J.H.T. Expression and distribution of surfactant proteins and lysozyme after prolonged hyperpnea. Am. J. Physiol. 270:1996;L320-L330.